| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| 2022-04-01 | Betz Stephen F. | Chief Scientific Officer | Sell | 8,328 | $21.43 | $178,474.87 | -3.2% | → |
| 2022-03-15 | Betz Stephen F. | Chief Scientific Officer | Sell | 3,123 | $18.94 | $59,149.62 | -2.3% | → |
| 2022-03-01 | Madan Ajay | Chief Development Officer | Sell | 9,000 | $19.88 | $178,920.00 | -4.8% | → |
| 2022-03-01 | Betz Stephen F. | Chief Scientific Officer | Sell | 3,123 | $19.73 | $61,616.79 | -2.2% | → |
| 2022-02-15 | Betz Stephen F. | Chief Scientific Officer | Sell | 3,123 | $18.64 | $58,212.72 | -2.5% | → |
| 2022-02-07 | Madan Ajay | Chief Development Officer | Sell | 13,411 | $17.83 | $239,084.60 | -7.2% | → |
| 2022-02-01 | Betz Stephen F. | Chief Scientific Officer | Sell | 3,123 | $18.79 | $58,681.17 | -2.4% | → |
| 2022-01-19 | Krasner Alan Seth | Chief Medical Officer | Sale+OE | 6,700 | $21.21 | $142,080.20 | -44.6% | → |
| 2022-01-18 | Betz Stephen F. | Chief Scientific Officer | Sell | 4,168 | $23.29 | $97,072.72 | -3.1% | → |
| 2022-01-03 | Betz Stephen F. | Chief Scientific Officer | Sell | 7,168 | $28.02 | $200,847.36 | -5.1% | → |
| 2021-12-28 | Betz Stephen F. | Chief Scientific Officer | Sell | 3,000 | $27.95 | $83,851.80 | -2.1% | → |
| 2021-12-15 | Betz Stephen F. | Chief Scientific Officer | Sell | 5,668 | $24.14 | $136,825.52 | -3.8% | → |
| 2021-12-01 | Betz Stephen F. | Chief Scientific Officer | Sell | 5,668 | $27.38 | $155,189.84 | -3.7% | → |
| 2021-11-16 | Betz Stephen F. | Chief Scientific Officer | Sell | 7,168 | $27.01 | $193,574.00 | -2.3% | → |
| 2021-11-08 | Betz Stephen F. | Chief Scientific Officer | Sell | 16,500 | $28.06 | $463,041.00 | -4.8% | → |
| 2021-11-01 | Fust Matthew K | Director | Sale+OE | 8,954 | $25.50 | $228,327.00 | -41.7% | → |
| 2021-11-01 | Betz Stephen F. | Chief Scientific Officer | Sell | 5,668 | $24.79 | $140,509.72 | -3.1% | → |
| 2021-10-27 | Betz Stephen F. | Chief Scientific Officer | Sell | 3,000 | $24.00 | $71,991.00 | -1.6% | → |
| 2021-10-25 | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | 1,200,000 | $19.80 | $23,760,000.00 | +30.3% | → |
| 2021-10-21 | Betz Stephen F. | Chief Scientific Officer | Sell | 1,042 | $21.10 | $21,983.60 | -0.6% | → |
| 2021-09-08 | Fust Matthew K | Director | Sale+OE | 6,046 | $25.50 | $154,173.00 | -32.5% | → |
| 2021-09-07 | Struthers Richard Scott | President & CEO | Sell | 30,000 | $25.00 | $750,000.00 | -10.0% | → |
| 2021-07-26 | Fust Matthew K | Director | Sale+OE | 5,000 | $19.59 | $97,950.00 | -28.5% | → |
| 2021-07-19 | Fust Matthew K | Director | Sale+OE | 5,000 | $19.50 | $97,500.00 | -28.5% | → |
| 2021-07-12 | Fust Matthew K | Director | Sale+OE | 5,000 | $20.71 | $103,550.00 | -28.5% | → |
| 2021-04-08 | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | 304,136 | $16.44 | $4,999,995.84 | +8.3% | → |
| 2020-12-03 | Struthers Richard Scott | President & CEO | Buy | 5,000 | $13.00 | $65,000.00 | New | → |
| 2020-07-16 | Struthers Richard Scott | President & CEO | Sell | 35,000 | $14.88 | $520,829.75 | -1.9% | → |
| 2020-04-17 | PERCEPTIVE ADVISORS LLC | 10% Owner | Buy | 1,071,428 | $14.00 | $14,999,992.00 | +41.4% | → |
| 2020-04-17 | Vivo Capital VIII, LLC | - | Sell | 330,598 | $15.45 | $5,106,752.20 | -4.2% | → |
| 2020-04-07 | Vivo Capital VIII, LLC | - | Sell | 306,115 | $13.81 | $4,226,833.00 | -5.2% | → |
| 2020-03-09 | Vivo Capital VIII, LLC | - | Sell | 528 | $19.50 | $10,296.00 | - | → |
| 2020-02-10 | Vivo Capital VIII, LLC | - | Sell | 1,451 | $21.40 | $31,051.40 | - | → |